Three Peaks Capital Management’s Allergan plc AGN Stock Holding History

Three Peaks Capital Management’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-10,950	Closed	-$2.98M	–	77
2015 Q3	$2.98M	Sell	10,950 -17,292	-61%	-$5.31M	0.73%	56
2015 Q2	$8.57M	Buy	28,242 +6,110	+28%	+$1.82M	2.26%	10
2015 Q1	$6.59M	Buy	22,132 +5,244	+31%	+$1.5M	2.26%	16
2014 Q4	$4.35M	Sell	16,888 -2,950	-15%	-$737K	2.14%	20
2014 Q3	$4.79M	Buy	19,838 +3,295	+20%	+$737K	2.68%	8
2014 Q2	$3.69M	Buy	16,543 +849	+5%	+$176K	2.55%	11
2014 Q1	$3.23M	Sell	15,694 -9,929	-39%	-$1.97M	2.53%	12
2013 Q4	$4.3M	Buy	+25,623	New	+$4.01M	2.16%	13

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Three Peaks Capital Management's AGN Position: Q4 2015 in Review

Three Peaks Capital Management sold out of Allergan plc (AGN) in Q4 2015, closing a stake of 10,950 shares — an estimated $2.98M sold.

Three Peaks Capital Management first reported a position in AGN in Q4 2013 and held it in 8 quarters. The position peaked at $8.57M in Q2 2015. 1,110 funds tracked by Wall St. Rank hold AGN as of Q4 2015.

Three Peaks Capital Management reported no remaining Allergan plc position as of Q4 2015 after selling out during the quarter.
Three Peaks Capital Management sold 10,950 Allergan plc shares in Q4 2015, an estimated $2.98M.
Three Peaks Capital Management first reported a position in Allergan plc in Q4 2013 and held it in 8 quarters.
Three Peaks Capital Management's Allergan plc position peaked at $8.57M in Q2 2015.
1,110 funds tracked by Wall St. Rank held Allergan plc as of Q4 2015.

Based on Three Peaks Capital Management's 13F filing for Q4 2015, filed 14 Jan 2016.